Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.

about

Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review Application of nanotechnologies for improved immune response against infectious diseases in the developing world

P2860

Q27489337-76335F06-34A6-4F10-847C-679119214966 Q33894321-B96B03F2-010C-4ADD-9438-49F87E285A54

P2860

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.

Item

http://www.wikidata.org/entity/Q36920320

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Nanomedicines in the treatment ...... on pegylated interferon-alpha.

@en

type

Item

label

Nanomedicines in the treatment ...... on pegylated interferon-alpha.

@en

prefLabel

Nanomedicines in the treatment ...... on pegylated interferon-alpha.

@en

P1476

Nanomedicines in the treatment ...... on pegylated interferon-alpha.

@en

P2093

Heinz Zoller

http://www.w3.org/2001/XMLSchema#string

Wolfgang Vogel

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study

Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.

The natural history of hepatitis C virus (HCV) infection.

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Hepatitis C in the HIV-Infected Person

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

PEGylation, successful approach to drug delivery

Treating HCV with ribavirin analogues and ribavirin-like molecules

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

P304

399-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/NANO.2006.1.4.399

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6118594

http://www.w3.org/2001/XMLSchema#string

P698

17722274

http://www.w3.org/2001/XMLSchema#string

P921

hepatitis C

Alcoal

peptide

human immunodeficiency virus infectious disease

Retroviridae infectious disease

manufactured product

macromolecular substances

P932

2676642

http://www.w3.org/2001/XMLSchema#string

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.

about

P2860

P2860

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932